New Delhi, Mumbai Oncocare (MOC) Cancer Care and Research Center and Gujarat Hemato Oncology Clinic-Vedanta (HOC) announced the merger of the two companies, a statement said.
The new entity is set to expand its reach across India with 22 community cancer care centers in Maharashtra, Madhya Pradesh and Gujarat, the companies' statement said.
"This merger will significantly expand access to advanced cancer treatments in Western India, impacting more than 22,000 lives and administering more than 60,000 chemotherapy treatments annually," it said.
Earlier, MOC had secured a significant investment of US$10 million from Tata Capital Healthcare Fund in January 2023.
The new entity is set to expand its reach across India with 22 community cancer care centers in Maharashtra, Madhya Pradesh and Gujarat, the companies' statement said.
"This merger will significantly expand access to advanced cancer treatments in Western India, impacting more than 22,000 lives and administering more than 60,000 chemotherapy treatments annually," it said.
Earlier, MOC had secured a significant investment of US$10 million from Tata Capital Healthcare Fund in January 2023.
